Anti-EGFR antibody therapy and skin toxicity: Retrospective analysis and role of pharmacists in protocol-based pharmacotherapy management
Int. Journal of Clinical Pharmacology and Therapeutics · 25.09.2026
DOI: 10.5414/cp205030 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, erschienen am 25.09.2026. Verfasst von Hajime Morita und 9 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Morita, H., Sakurada, T., Hirano, A., Makuuchi, M., Kishimoto, S., Minatogawa, H., Sakaue, I., Sunakawa, Y., Sato, N., & Yamazaki, S. (2026). Anti-EGFR antibody therapy and skin toxicity: Retrospective analysis and role of pharmacists in protocol-based pharmacotherapy management. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp205030
Vancouver
Morita H, Sakurada T, Hirano A, Makuuchi M, Kishimoto S, Minatogawa H, et al. Anti-EGFR antibody therapy and skin toxicity: Retrospective analysis and role of pharmacists in protocol-based pharmacotherapy management. Int. Journal of Clinical Pharmacology and Therapeutics. 2026. doi:10.5414/cp205030
BibTeX
@article{Morita2026,
author = {Morita, Hajime and Sakurada, Tomoya and Hirano, Ayami and Makuuchi, Mari and Kishimoto, Sayaka and Minatogawa, Hiroko and Sakaue, Ikko and Sunakawa, Yu and Sato, Nobunori and Yamazaki, Shingo},
title = {Anti-EGFR antibody therapy and skin toxicity: Retrospective analysis and role of pharmacists in protocol-based pharmacotherapy management},
journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
year = {2026},
doi = {10.5414/cp205030}
}
EUVIMED